Insider Selling: athenahealth, Inc. (ATHN) CEO Sells 4,000 Shares of Stock
athenahealth, Inc. (NASDAQ:ATHN) CEO Jonathan Bush sold 4,000 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $139.77, for a total value of $559,080.00. Following the completion of the sale, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at approximately $44,699,424.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Jonathan Bush also recently made the following trade(s):
- On Tuesday, August 1st, Jonathan Bush sold 4,000 shares of athenahealth stock. The shares were sold at an average price of $143.31, for a total value of $573,240.00.
- On Monday, July 3rd, Jonathan Bush sold 4,000 shares of athenahealth stock. The shares were sold at an average price of $140.52, for a total value of $562,080.00.
athenahealth, Inc. (NASDAQ:ATHN) traded up 0.27% on Wednesday, reaching $139.67. The company had a trading volume of 248,861 shares. athenahealth, Inc. has a 52-week low of $90.11 and a 52-week high of $158.66. The firm has a market capitalization of $5.58 billion, a price-to-earnings ratio of 177.25 and a beta of 1.79. The stock’s 50-day moving average price is $142.48 and its 200 day moving average price is $128.22.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The firm had revenue of $301.10 million during the quarter, compared to analysts’ expectations of $298.68 million. During the same period in the prior year, the company earned $0.34 EPS. The firm’s revenue was up 15.0% on a year-over-year basis. On average, equities analysts anticipate that athenahealth, Inc. will post $1.91 earnings per share for the current fiscal year.
A number of institutional investors have recently made changes to their positions in ATHN. Janus Henderson Group PLC purchased a new stake in athenahealth during the 2nd quarter worth $713,856,000. BlackRock Inc. boosted its position in athenahealth by 30,642.6% during the 1st quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after purchasing an additional 1,594,643 shares during the period. Morgan Stanley boosted its position in athenahealth by 9.7% during the 1st quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after purchasing an additional 397,837 shares during the period. Elliott Management Corp purchased a new stake in athenahealth during the 2nd quarter worth $52,706,000. Finally, Clearbridge Investments LLC boosted its position in athenahealth by 61.8% during the 1st quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after purchasing an additional 347,133 shares during the period.
Several equities research analysts recently commented on ATHN shares. William Blair reaffirmed a “market perform” rating on shares of athenahealth in a report on Friday, July 21st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $140.00 price target (up previously from $118.00) on shares of athenahealth in a report on Friday, May 19th. Argus started coverage on athenahealth in a report on Friday, July 7th. They issued a “hold” rating for the company. Citigroup Inc. reiterated a “buy” rating and issued a $163.00 price objective (up from $128.00) on shares of athenahealth in a research report on Monday, June 5th. Finally, J P Morgan Chase & Co set a $136.00 price objective on athenahealth and gave the stock a “hold” rating in a research report on Wednesday, July 19th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and thirteen have given a buy rating to the company’s stock. athenahealth currently has an average rating of “Hold” and a consensus price target of $149.09.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.